Entries of Zuckermann, A. on the publication server

Eisen, H.J., Kobashigawa, J., Starling, R.C., Pauly, D.F., Kfoury, A., Ross, H., Wang, S.-S. , Cantin, B., Van Bakel, A., Ewald, G., Hirt, S., Lehmkuhl, H., Keogh, A., Rinaldi, M. , Potena, L. , Zuckermann, A., Dong, G. , Cornu-Artis, C. and Lopez, P. (2013) Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial. American Journal of Transplantation 13 (5), pp. 1203-1216. Fulltext not available.

Epailly, E., Eisen, H., Pauly, D., Hirt, S., Lehmkuhl, H., Andreassen, A., Rinaldi, M., Yonan, N., Potena, L. , Zuckermann, A., Dong, G. , Panis, C., Lopez, P. and Kobashigawa, J. (2012) 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study. Transplantation Journal 94 (10S), p. 127. Fulltext not available.

Rinaldi, M., Wang, S. S., Hirt, S., Eisen, H., Keogh, A., Boffini, M., Bara, C., Zuckermann, A., Lopez, P., Cines, M. and Lehmkuhl, H. (2012) mTOR-Inhibitor-Attributed Events: Review of 2-Year Safety Data in Heart Transplant Recipients Receiving Everolimus Vs MMF in the Randomised Multi-Centre 2310 Study. Transplantation Journal 94 (10S), p. 129. Fulltext not available.

Zuckermann, A., Eisen, H., Kobashigawa, J., Ross, H., Wang, S., Lehmkuhl, H., Rinaldi, M., Torre, G., Yonan, N., Arizon, J., Pellegrini, C., Lopez, P., Dong, G., Panis, C. and Hirt, S. (2011) 245 Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients. The Journal of Heart and Lung Transplantation 30 (4), S87. Fulltext not available.